Fosun Pharma repurchases 810,300 shares in Shanghai
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SSE:600196) announced that on June 26, 2025, it repurchased 810,300 of its A-shares on the Shanghai Stock Exchange. The prices ranged from RMB 24.63 to RMB 24.7 per share, resulting in a total expenditure of RMB 19,998,413. Following the buyback, the number of shares held by the company increased to 2,118,488,825 and are held as treasury. The company confirms the repurchase was conducted according to applicable local rules for share buybacks on the exchange. This repurchase was conducted by the company's board of directors.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime